openPR Logo
Press release

Polio Vaccines Market – Global Industry Insights and Opportunity Analysis 2025

10-09-2017 04:14 PM CET | Health & Medicine

Press release from: Pharmaceutical Report By CMI

Polio Vaccines Market – Global Industry Insights

Poliomyelitis is highly infectious disease caused by poliovirus. It is also known as polio or infantile paralysis. The virus belongs to genus Enterovirus which is a type of single-stranded RNA virus. There are three serotypes of poliovirus: P1, P2 and P3 and development of immunity to one serotype does not produce significant immunity to the other serotypes. The virus is transmitted primarily via the faecal-oral route, by ingesting contaminated food or water and less commonly through oral-oral route. Those who are infected may spread the disease for up to 6 weeks even if no symptoms are present. Poliovirus colonizes the gastrointestinal tract, specifically intestine and oropharynx and after about a week, it invades local lymphoid tissue and enters bloodstream, and then may infect cells of the central nervous system. Replication of poliovirus in motor neurons of the anterior horn and brain stem results in destruction of cell and thus causes the typical manifestations of poliomyelitis. This is projected to favour a significant growth for polio vaccines market over the forecast period.

Symptoms of Poliomyelitis:

Polio mainly affects children under 5 years of age. Up to 70% of all the infections in children are without any symptoms and about 25-30% of infections in children causes’ nonspecific illness without clinical or laboratory evidence of central nervous system invasion. This has created a gesture for the organizations to focus on the vaccines options for making prophylactic approach towards the prevention of the disorder, which in turn is expected to fuel the polio vaccines market in the near future.

Polio vaccines market relies on the fact that around 1% of polio cases can develop into paralytic polio which causes paralysis in the spinal cord (spinal polio), brainstem (bulbar polio), or both (bulbospinal polio).According to WHO, 1 in 200 infections leads to irreversible paralysis. Among those paralysed, 5% to 10% die when their breathing muscles become immobilized. The statistics regarding the prevalence of the disorder is expected to be one of the crucial factor that is to fuel the market of polio vaccines.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/380

In a report, WHO has reported that Polio cases have decreased by over 99% since 1988, from an estimated 350 000 cases then, to 74 reported cases in 2015. The reduction is the result of the global effort to eradicate the disease. Of the 3 serotypes, P2 was eradicated in 1999 and number of cases of P3 has decreased significantly.

Market scenario varies with change in continents and is expected to affect the polio vaccines market:

There are two types of vaccine that protect against polio:

-Inactivated poliovirus vaccine (IPV): given as an injection.
-Oral poliovirus vaccine (OPV): given orally

OPV has not been used in the United States since 2000 but is still used in many parts of the world but, IPV is still available in US.

Polio vaccines market is segmented on the basis of product and end user:

Segmentation on the basis of product:

-IPV
-OPV

Segmentation on the basis of end user:

-Hospital
-Clinics
-Public Services
-Others

America has been declared polio free in 1994. In 2004, polio was declared to be eliminated from Australia, China and other 37 Pacific countries. Since 2011, there has been no cases of wild polio infections in India. This factor is projected to hinder the polio vaccines market in the near future.

There are only 3 countries left in which wild polio infections still persist; Afghanistan, Nigeria, and Pakistan, which are somehow the reason for significant growth in the polio vaccines market in the near future.

Indigenous wild poliovirus type 2 has not been detected since 1999. In 2015, the World Health Assembly agreed that all Member States which currently use OPV should prepare for the global withdrawal of the type 2 component of OPV in April 2016. According to WHO, member countries are required to introduce at least 1 dose of the IPV into routine immunization schedule.

Sanofi Pasteur and Bilthoven Biologicals/ Serum Institute of India are the 2 companies which was awarded in 2014 by UNICEF for the supply of IPV in 1, 5 and 10 dose vials, and long term supply agreements were established through to 2018.

Click here to know more about this report:https://www.coherentmarketinsights.com/ongoing-insight/polio-vaccines-market-380

Since 2000, UNICEF OPV procurement has averaged 1.8 Bn doses annually. GPEI launched the “End Game Strategic Plan 2013-2018” at the World Health Assembly in May 2013. This comprehensive strategy focuses on eliminating both wild and vaccine-derived polio incidence through routine immunisation programs thereby gradually replacing OPV use with IPV vaccine. This in turn is expected to favour the growth in polio vaccines industry in the near future.

According to UNICEF report, Bio Farma (Indonesia), GlaxoSmithKline (GSK) (UK) and Sanofi Pasteur (France) are the only OPV bulk manufacturers. Novartis (Switzerland) has stopped their manufacture of OPV.

Other players of polio vaccine market are: Merck & Co, Bibcol, Pfizer, Beijing Tiantan Biological, Bio-Med, Panacea Biotec Ltd, Adithya Vaccine Pharma, Sinovac Biotech Ltd, IPOLand Aventis Pasteur.

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Polio Vaccines Market – Global Industry Insights and Opportunity Analysis 2025 here

News-ID: 763600 • Views: 237

More Releases from Pharmaceutical Report By CMI

Rising prevalence of diabetes is a major factor driving growth of the diabetic f …
Diabetic foot ulcers is a common condition in diabetic patients. It is a disabling disorder, which might lead to amputation of the leg. Mortality due to diabetic foot ulcers is high and chances of recurrence of cured foot ulcers is also high and this in turn leads to increasing demand for proper treatment of diabetic foot ulcers. Diabetic foot ulcer is caused due to neuropathic and vascular changes in the
Glucagon-Like Peptide-1 (Glp-1) Analogs Market Global Industry Insights, Trends, …
Glucagon-like peptide-1 (GLP-1) analogs also known as incretin mimetics are class of drugs indicated for type-2 diabetes mellitus to lower the blood sugar level. GLP-1 analogs prevents the breakdown of GLP-1, thereby enhancing the glucose depended insulin release, suppresses the glucagon release (which reduces hepatic glucose output), and reduces gastric emptying rate (resulting in weight loss from reduced appetite). GLP-1 analogs do not cause hypoglycemia like other class of anti-diabetic
Multiple Sclerosis Therapeutics Market to Surpass US$ 24.4 Billion by 2025
Increasing prevalence of multiple sclerosis to augment market growth Multiple sclerosis is a widespread disabling neurological condition, mostly diagnosed in people in the age group 20–50 years. According to the Multiple Sclerosis Foundation, 2017, this autoimmune condition affects 2.5 million people with the global incidence of around 7 cases per 100,000 people per year. The study also states that prevalence rates varies between ethnic and geographical latitudes, ranging from 50 to
Diabetic Foot Ulcers Treatment Market to Surpass US$ 9.49 Billion Threshold by 2 …
Diabetic foot ulcers is a common condition in diabetic patients. It is a disabling disorder, which might lead to amputation of the leg. Mortality due to diabetic foot ulcers is high and chances of recurrence of cured foot ulcers is also high and this in turn leads to increasing demand for proper treatment of diabetic foot ulcers. Diabetic foot ulcer is caused due to neuropathic and vascular changes in the

All 5 Releases


More Releases for Polio

Polio Vaccines Market Opportunity Analysis, 2018-2026
Poliomyelitis is highly infectious disease caused by poliovirus. It is also known as polio or infantile paralysis. The virus belongs to genus Enterovirus which is a type of single-stranded RNA virus. There are three serotypes of poliovirus: P1, P2 and P3 and development of immunity to one serotype does not produce significant immunity to the other serotypes. The virus is transmitted primarily via the fecal-oral route, by ingesting contaminated food
Polio Vaccines Market - Global Industry Insights, 2025
Poliomyelitis is highly infectious disease caused by poliovirus. It is also known as polio or infantile paralysis. The virus belongs to genus Enterovirus which is a type of single-stranded RNA virus. There are three serotypes of poliovirus: P1, P2 and P3 and development of immunity to one serotype does not produce significant immunity to the other serotypes. The virus is transmitted primarily via the fecal-oral route, by ingesting contaminated food
Polio Vaccine Market Report Analysis & 2017 Forecast Research Report
Summary This report helps to analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the EMEA (Europe, Middle East and Africa) Polio Vaccine Market Report 2017 Description According to the EMEA (Europe, Middle East and Africa) Polio Vaccine Market report, the (Europe, Middle East and Africa) Polio Vaccine Market is estimated to grow at a fast rate through the forecast period of
2017 Report: Global Polio Vaccine Market Competition by Manufacturers
This report studies Polio Vaccine in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering Astellas Pharma CSL Limited Emergent BioSolutions GlaxoSmithKline Johnson&Johnson MedImmune Merck ... Request a sample of this report @ http://www.reportsweb.com/inquiry&RW0001609399/sample . Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of
Global POLIO VACCINE Market Research Report 2017
Polio Vaccine Report This report studies sales (consumption) of Polio Vaccine in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering Astellas Pharma CSL Limited Emergent BioSolutions GlaxoSmithKline Johnson&Johnson MedImmune Merck Try Sample Report @ https://www.wiseguyreports.com/sample-request/982168-global-polio-vaccine-sales-market-report-2017 Market Segment by Regions, this report splits Global into several key Regions, with sales
Global Polio Vaccine Market Report 2017 | DecisionDatabases.com
The Report added on Polio Vaccine Market added by DecisionDatabases.com to its huge database. This research study is segmented on the basis of applications, technology, geography, and types. The Report provides a detailed Polio Vaccine Industry overview along with the analysis of industry’s gross margin, cost structure, consumption value and sale price. The leading companies of the Polio Vaccine Market, manufacturers, and distributors are profiled in the report along with